Investment Objective The investment seeks long-term capital growth. The fund invests primarily in equity securities issued by U.S. companies. It currently anticipates that substantially all of its portfolio will consist of securities of companies …
Correspondence to: T Y Aw, Department of Molecular and Cellular Physiology, LSU Health Sciences Center, 1501 …
Veeva (VEEV) strengthens its position by providing the life sciences industry with a streamlined commercial database besides notable technological innovations.
The Surrey, Britain-based company said it had a loss of 21 cents per share. Earnings, adjusted for one-time gains and costs, were $1.31 per share. The results exceeded Wall Street expectations. The average ...